RJA
NPTN

Raymond James & Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Raymond James & Associates’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-22,800
Closed -$189K – 3742
2018
Q3 		$189K Sell
22,800
-57,550
-72% -$438K ﹤0.01% 3315
2018
Q2 		$501K Sell
80,350
-90,817
-53% -$577K ﹤0.01% 2690
2018
Q1 		$1.17M Buy
171,167
+146,867
+604% +$933K ﹤0.01% 2020
2017
Q4 		$160K Buy
+24,300
New +$148K ﹤0.01% 3124
2016
Q2 		– Sell
-11,152
Closed -$157K – 3110
2016
Q1 		$157K Buy
+11,152
New +$115K ﹤0.01% 2633

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James & Associates's NPTN Position: Q4 2018 in Review

Raymond James & Associates sold out of NEOPHOTONICS CORP (NPTN) in Q4 2018, closing a stake of 22,800 shares — an estimated $189K sold.

Raymond James & Associates first reported a position in NPTN in Q1 2016 and held it in 5 quarters. The position peaked at $1.17M in Q1 2018. 115 funds tracked by Wall St. Rank hold NPTN as of Q4 2018.

  • Raymond James & Associates reported no remaining NEOPHOTONICS CORP position as of Q4 2018 after selling out during the quarter.
  • Raymond James & Associates sold 22,800 NEOPHOTONICS CORP shares in Q4 2018, an estimated $189K.
  • Raymond James & Associates first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 5 quarters.
  • Raymond James & Associates's NEOPHOTONICS CORP position peaked at $1.17M in Q1 2018.
  • 115 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2018.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.